ArticlePDF Available

Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress



Mitochondria combine the production of energy with an efficient chain of reduction-oxidation (redox) reactions but also with the unavoidable production of reactive oxygen species. Oxidative stress leading to mitochondrial dysfunction is a critical factor in many diseases, such as cancer and neurodegenerative and lifestyle-related diseases. Effective antioxidants thus offer great therapeutic and preventive promise. Investigating the efficacy of antioxidants, we found that a carotenoid, astaxanthin (AX), decreased physiologically occurring oxidative stress and protected cultured cells against strong oxidative stress induced with a respiratory inhibitor. Moreover, AX improved maintenance of a high mitochondrial membrane potential and stimulated respiration. Investigating how AX stimulates and interacts with mitochondria, a redox-sensitive fluorescent protein (roGFP1) was stably expressed in the cytosol and mitochondrial matrix to measure the redox state in the respective compartments. AX at nanomolar concentrations was effective in maintaining mitochondria in a reduced state. Additionally, AX improved the ability of mitochondria to remain in a reduced state under oxidative challenge. Taken together, these results suggest that AX is effective in improving mitochondrial function through retaining mitochondria in the reduced state.
Astaxanthin protects mitochondrial redox state and
functional integrity against oxidative stress.
Alexander M Wolf
, Sadamitsu Asoh
, Hidenori Hiranuma
, Ikuroh Ohsawa
Kumiko Iio
, Akira Satou
, Masaharu Ishikura
, Shigeo Ohta
Department of Biochemistry and Cell Biology,
The Center of Molecular Hydrogen Medicine
Institute of Development and Aging Sciences, Nippon Medical School,
1-396 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-8533 Japan
Life Science Institute, Yamaha Motor Co. Ltd.
3001-10 Kuno, Fukuroi, Shizuoka, 437-0061 Japan
*Corresponding author. Fax: +81-44-733-9268 Tel: +81-44-733-9267
E-mail address: (S. Ohta)
Department of Biochemistry and Cell Biology, Institute of Development and Aging
Sciences, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki,
Kanagawa, 211-8533 Japan
Mitochondria combine the production of energy with an efficient chain of
reduction-oxidation (redox) reactions, but also with the unavoidable production of
reactive oxygen species (ROS). Oxidative stress leading to mitochondrial dysfunction
is a critical factor in many diseases, such as cancer and neurodegenerative and
lifestyle related diseases. Effective antioxidants thus offer great therapeutic and
preventive promise. Investigating the efficacy of antioxidants, we found that a
carotenoid, astaxanthin (AX) decreased physiologically occurring oxidative stress and
protected cultured cells against strong oxidative stress induced with a respiratory
inhibitor. Moreover, AX improved maintenance of a high mitochondrial membrane
potential and stimulated respiration. Investigating how AX stimulates and interacts
with mitochondria, a redox-sensitive fluorescent protein (roGFP1) was stably
expressed in the cytosol and mitochondrial matrix to measure the redox state in the
respective compartments. AX at nanomolar concentrations was effective in
maintaining mitochondria in a reduced state. Additionally, AX improved the ability
of mitochondria to remain in a reduced state under oxidative challenge. Taken
together, these results suggest that AX is effective in improving mitochondrial
function through retaining mitochondria in the reduced state.
Keywords: Oxidative stress; Mitochondrial membrane potential; Oxygen
consumption; Redox-sensitive GFP; Astaxanthin; Metabolic syndrome
1. Introduction
Oxidative stress is involved in the pathogenesis of atherosclerosis [1,2], cancer
[3], diabetes [4,5], neurodegenerative [6-8] and other diseases, as well as in the aging
process itself. Antioxidant treatment has therefore great promise in alleviating some
of the detrimental effects of oxidative stress [9], and several types of antioxidants
stimulate lipid oxidation, which may have merit in improving metabolic syndrome
[10-12]. A huge selection of both natural and synthetic antioxidants is available and
can be ingested easily with, in the case of food-derived antioxidants, little concern
about adverse side effects. This attractiveness has on one hand led a multi-billion
dollar supplement industry often based on anecdotal evidence [13,14] and, on the
other hand, to large scale clinical trials to determine efficacy, often with disappointing
results [15,16]. Selecting the most promising substances is therefore important to
avoid costly failures [17].
Cellular reduction-oxidation (redox) state is directly affected in conditions of
oxidative stress, and depletion of endogenous antioxidants plays a critical role in
disease progression [18]. Genetically encoded indicators can be targeted
to specific
organelles of interest and expressed
in a wide variety of cells and organisms [19]. The
indicator used in this work, redox-sensitive green fluorescent proteins (roGFP1),
allows the real-time visualization of the oxidation
state of the indicator [20,21]. In
(GFP with mutations C48S, S147C, and Q204C), two surface-exposed
cysteines are placed at
positions 147 and 204 on adjacent β-strands close to the
Disulfide formation between the cysteine residues promotes protonation
of the chromophore and increases the excitation spectrum peak
near 400 nm at the
expense of the peak near 490 nm. The ratios
of fluorescence from excitation at 400
and 490 nm indicate the
extent of oxidation and thus the redox potential while
out the amount of indicator and the absolute optical sensitivity [20,21]. In
contrast to its close cousin roGFP2, roGFP1 also offers the advantage to be insensitive
to variations in pH [21].
Astaxanthin (AX), a red-orange carotenoid pigment, is a powerful antioxidant
that occurs naturally in a wide variety of living organisms and has positive effects on
cancer, diabetes, the immune system, and ocular health [22]. Health benefits such as
cardiovascular disease prevention, immune system boosting, bioactivity against
Helicobacter pylori, and cataract prevention, have been associated with AX [23]. Oral
supplementation of a synthetic AX derivative reduced lipid peroxidation levels and
provided significant cardioprotection, consistent with its lipophilic nature and in vitro
antioxidant properties [24]. However, the concentrations of AX used in these studies
were generally much higher than what can be achieved using supplementation [25] or
dietary intervention [26]. We investigated how AX could exert an antioxidant effect in
a concentration range chosen close to what can be achieved using supplements and/or
2. Materials and methods
2.1. Cell culture
HeLa human cervical cancer cells were maintained in DMEM/F12 medium
(Invitrogen Japan K.K.) supplemented with 10% fetal bovine serum (FBS).
Undifferentiated PC12 rat pheochromocytoma cells were cultured in DMEM
supplemented with 10% FBS and 5% heat-inactivated horse serum. Jurkat
immortalized T lymphocyte cells were cultivated in RPMI1640 (Invitrogen)
containing 10% FBS. All media contained 100 Units/ml penicillin and 100 µg/ml
streptomycin, and all cell types were maintained at 37°C in a humidified atmosphere
of 5% CO
and 95% air.
2.2. Transfection
HeLa cells were transfected with the mammalian expression vector pEGFP-N1
(Clontech, Takara Bio Inc., CA) containing roGFP1 (for expression in the cytosol) or
roGFP1 with a mitochondrial targeting sequence (pyruvate dehydrogenase E1 subunit
leader sequence, for expression in mitochondria) using the Effectene Transfection
Reagent (Qiagen Japan) according to the manufacturer’s protocol. Stable transfectants
were selected using 400 µg/ml Geneticin (Invitrogen) for more than 4 weeks, and
cloned. Expression of roGFP1 was confirmed by its fluorescence.
2.3. Cell viability
Antimycin A (Sigma) was dissolved to 50 mg/ml in DMSO. The medium was
changed to DMEM supplemented with 1.0% FBS over night, and the PC12 cells then
treated with AX (Sigma) at the indicated concentrations for 6 and 24 h in DMEM
supplemented with 1.0% FBS. After AX treatment, 20 µg/ml antimycin A was added
(final DMSO concentration: 0.1%) and the cells incubated for 20 h. The number of
live/dead cells was counted with a fluorescence microscope (Nikon AZ100, Tokyo)
using the LIVE/DEAD cell viability kit for mammalian cells (Invitrogen) and the
survival rate expressed as live cells/(live cells + dead cells).
2.4 Fluorescence microspcopy
Fluorescence images were recorded using a multi-dimensional imaging
workstation (AS MDW, Leica Microsystems, Wetzlar, Germany) consisting of a
tunable light source (Polychrome IV monochromator, Till Photonics, Gräfelfing,
Germany), an inverted epifluorescence microscope (DM IRE2, Leica Microsystems)
contained in a climate chamber maintained at 37°C, and a cooled CCD camera
(CoolSnap HQ, Roper Scientific, Princeton, NJ). A 0.35X demagnifiying lens (Leica
Microsystems) was inserted between the microscope and the CCD camera. The
components were controlled by custom-made software written in C (Bloodshed
Dev-C++) and LabVIEW (National Instruments, Austin, TX).
2.5 Redox-sensitive fluorescent protein fluorescence recording
HeLa cells expressing roGFP1 were washed with PBS and fluorescence
recorded. Hydrogen peroxide was diluted from a 30% (w/v) stock solution with PBS
(37 °C) to 500 µM, and added to reach the indicated concentration. Dual excitation
ratio imaging was performed using a 20X objective (N.A. 0.5) and 800 ms exposure
time at 410 nm and 490 nm excitation wavelength. A 500 nm short pass excitation
filter (E500SP), 515 nm extended range dichroic mirror (515DCXR) and 520-600 nm
band pass emission filter (HQ560/80, all from Chroma Technology Corporation,
Rockingham, VT) was used for both wavelengths.
Fluorescence data was analyzed using MATLAB (MathWorks, Version 7
Release 14, Natick, MA). After subtracting background fluorescence and CCD dark
field, areas corresponding to cells were automatically selected using the criteria of
more than 10 connected pixels with fluorescence intensity above both 3% of the
maximum fluorescence in the field of view and more than 8 standard deviations above
the background noise/intensity in the image obtained with 410 nm excitation
wavelength. Such regions were marked, and visually confirmed to correspond to cells
expressing fluorescent protein. The fluorescence ratio was formed by dividing the
fluorescence integral of such regions at 410 nm and 490 nm excitation. When
following the time course of the fluorescence ratio of individual cells, in order to be
counted, cells had to fulfil the above criteria at every recorded time point.
2.6 Mitochondrial membrane potential
A 0.5 mM stock solution of JC-1 (Invitrogen) was prepared in equal volumes
of ethanol and DMSO. HeLa cells were cultured in DMEM/F12 + 10% FBS with or
without 800 nM AX (control: DMSO) for 6 h, 1 day and 2 days, then stained with 250
nM JC-1 in culture medium for 60 min, washed with PBS and fluorescence recorded
immediately, all at 37°C. Dual excitation ratio imaging was performed using a 20X
objective (N.A. 0.5) and 200 ms exposure time at 520 nm and 570 nm excitation
wavelength. A 580 nm short pass excitation filter (E580SP), 585 nm extended range
dichroic mirror (585DCXR) and 590-670 nm band pass emission filter (HQ635/60, all
from Chroma Technology Corporation) was used for both excitation wavelengths.
Fluorescence data was analyzed using MATLAB (MathWorks, Version 7 Release 14).
After subtracting background (dark field) fluorescence, areas corresponding to cells
were automatically selected using the criteria of more than 10 connected pixels with
fluorescence intensity above both 3 % of the maximum fluorescence in the field of
view and more than 8 standard deviations above the background noise/intensity in the
image obtained with 520 nm excitation wavelength. The fluorescence ratio was
formed by dividing the fluorescence integral of all such regions at 570 nm and 520 nm
excitation. The field of view usually contained about 100 to 200 cells.
2.7 Superoxide measurement
HeLa cells were cultured in DMEM/F12 + 10% FBS with or without 800 nM
AX (control: DMSO) for 6 h, 1 day and 2 days, then exposed to 30 µg/ml antimycin A
for 15 min, then 250 nM MitoSOX Red (Invitrogen) and 500 nM Hoechst34580
(Invitrogen) added and incubated for 60 min, and fluorescence recorded using a 20X
(N.A. 0.5) objective. Hoechst34580 fluorescence was excited at 395 nm in
combination with a 500 nm short pass excitation filter (E500SP), 515 nm extended
range dichroic mirror (515DCXR) and 520-600 nm band pass emission filter
(HQ560/80). Ethidium (MitoSOX Red oxidation product) fluorescence was excited at
520 nm and recorded using a 580 nm short pass excitation filter (E580SP), 585 nm
extended range dichroic mirror (585DCXR) and 590-670 nm band pass emission filter
(HQ635/60). Fluorescence data was analyzed using MATLAB (MathWorks, Version 7
Release 14). After subtracting background (dark field) fluorescence, cell nuclei were
automatically detected using the criteria of more than 25 connected pixels with
fluorescence intensity above both 20 % of the maximum fluorescence in the field of
view and more than 10 standard deviations above the background noise/intensity in
the Hoechst 34580 image. Mean ethidium fluorescence intensity in the area above the
nucleus was used as the measure of superoxide production.
2.8 Flow cytometry
Jurkat cells were cultivated in medium in the presence or absence (DMSO) of
AX (800 nM) for 6 h, 1 day and 2 days without medium change. There was no
difference among the growth rates of these cell cultures. For detection of superoxide
anion, cells were incubated with antimycin A (30 µg/ml) for 10 min. Then,
MitoSOX Red (250 nM) was added. After 1 h, the cells were analyzed by flow
cytometry (Cell Lab Quanta system, Beckman Coulter Inc., Chaska, MN). For
detection of hydroxyl peroxides, cells were incubated with H
DCFDA (20 µ M,
Invitrogen). After 15 min, antimycin A (30 µg/ml) was added. One hour later, the
cells were analyzed by flow cytometry as above. Ten thousand cells of normal size
(assessed by forward scattering) were analyzed under each condition.
2.9 Physiologically occurring (basal) oxidative stress
Cells were cultured in DMEM/F12 + 10%FBS with or without 800 nM AX
(control: DMSO) for 2 days, then incubated with 20 µM H
DCFDA and 500 nM
Hoechst34580 in medium for 60 minutes, washed with PBS and the
dichlorofluorescein (DCF) fluorescence of individual cells measured immediately
afterwards using a 20X objective (N.A. 0.5). Fluorescence was recorded using the
BGR triple band pass filter set (Leica Microsystems). Hoechst34580 was excited at
403 nm and DCF at 496 nm wavelength. Fluorescence data was analyzed using
MATLAB (MathWorks, Version 7 Release 14). After subtracting background
(darkfield) fluorescence, cell nuclei were automatically detected using the criteria of
more than 25 connected pixels with fluorescence intensity above both 5 % of the
maximum fluorescence in the field of view and more than 10 standard deviations
above the background noise/intensity in the Hoechst 34580 image. Mean DCF
fluorescence intensity in the area above the nucleus was used as the measure of
oxidative stress.
2.10 Oxygen consumption
HeLa cells were cultured in DMEM/F12 + 10% FBS with or without 800
nM AX (control: DMSO) for 6 h, 1 day and 2 days, trypsinized and resuspended in
DMEM/F12. Oxygen consumption was measured using the Oxygen Meter Model 781
and the Mitocell MT200 closed respiratory chamber (Strathkelvin Instruments, North
Lanarkshire, UK), continuously stirred at 37 °C. The oxygen respiration rate was
calculated in the following three conditions: basal rate (no additions), state 4 (after
addition of 2 µM oligomycin (Sigma)), uncoupled (after addition of 80 µM DNP
(Sigma)) using the Strathkelvin 949 Oxygen System software. Cell concentration was
determined using a hemocytometer.
2.11 Confocal microscopy
To confirm targeting of roGFP1 to the mitochondrial matrix, HeLa cells
expressing the mitochondrial targeting vector were cultured in a glass bottom dish and
stained with 40 nM tetramethyl rhodamine methyl ester (TMRM, Molecular Probes,
Invitrogen) for 20 minutes. Fluorescence was observed using a FluoView FV300
confocal microscope (Olympus, Tokyo, Japan) with a 60X (N.A. 1.4) oil immersion
objective. roGFP1 was excited at 488 nm and emission collected above 510 nm, while
TMRM was excited at 543 nm and emission collected above 570 nm.
2.12 Statistical calculations
Statistical significance was determined using the unpaired two-tailed student’s
t-test in Excel (Microsoft, Redmond, WA) or one-way analysis of variance (ANOVA)
followed by a Tukey-Kramer multiple comparison test in Matlab (MathWorks,
Version 7 Release 14). Error bars indicate the standard deviation of three or more
measurements. The number of asterisks indicates statistical significance. Specifically,
* indicates p < 0.05, ** indicates p < 0.01 and *** indicates p < 0.001.
3. Results
3.1. AX improves cell survival under oxidative stress
To test whether AX protects cells against oxidative stress, we exposed rat
adrenal pheochromocytoma (PC12) cells, a neuronal model cell line shown to be
sensitive to oxidative stress [27], to antimycin A. Antimycin A, an inhibitor of
complex III of the electron transport chain, induces oxidative stress by increasing
mitochondrial superoxide production [28] (see also Fig. 2B & 2E). Preincubation with
AX for 6 h did not significantly increase PC12 cell survival, but when cells were
exposed to AX for 24 hours, a significant increase in the number of surviving cells
was observe with more than 200 nM AX, demonstrating that AX was able to protect
PC12 cells against oxidative stress at relatively low concentrations (Fig. 1). The effect
was concentration dependent, with 400 nM AX being more protective than 100 nM
AX (p < 0.01).
3.2. AX reduces basal oxidative stress levels but not acute oxidative stress
To determine the mechanism by which AX protects against oxidative stress,
we determined whether AX was able to directly scavenge superoxide radical. Human
cervial cancer (HeLa) and T lymphocyte (Jurkat) cells were exposed to antimycin A as
an acute stress model, and oxidation of the superoxide-sensitive probe MitoSOX Red
quantified as described in Materials and methods. Preincubation of cells with 800 nM
AX did not significantly reduce the amount of superoxide detected (Fig. 2A),
suggesting that AX did not scavenge excess amounts of superoxide under this
unphysiological condition. Similarly, Jurkat cells were treated with antimycin A
generated superoxide anion (as assessed by MitoSOX Red) and reactive peroxides (as
assessed by H
DCFDA) to a great extent (Fig. 2B & 2E). In these flow cytometry
experiments, the population of cells with an intensity of 1000 or more (marked with *
in Fig. 2B and 2C) was between 2 and 4 % of the cells analyzed. Quantitative analysis
revealed no significant difference in the fluorescence intensity of oxidized MitoSOX
product (Fig. 2C) or DCF (Fig. 2F) between AX-treated or non-treated cells, even
when cells were treated with AX for 2 days. Post-addition of AX did not change
fluorescent patterns of the antimycin A-treated cells without AX-treatment (data not
shown), indicating that AX does not interfere with fluorescence of oxidized MitoSOX
and DCF.
However, when the basal level of oxidative stress, that is the physiologically
occurring oxidative stress, in HeLa cells was determined using the oxidant sensitive
probe 2’,7’-dichlorodihydrofluorescein, AX significantly reduced the amount of
fluorescent oxidation product (DCF) produced (Fig. 2D), indicating that AX is able to
reduce endogenous oxidative stress. This signifies that there is a low but detectable
amount of endogenous oxidative stress under normal culture conditions, which AX
can reduce.
3.3. AX helps maintaining the mitochondrial membrane potential
We proceeded to determine whether such endogenous oxidants affect cellular
function and whether AX could influence it. The mitochondrial membrane potential
was quantified using the aggregate-forming probe JC-1 [29]. Using dual excitation
ratio imaging, we observed a significantly higher mitochondrial membrane potential
when AX was present in culture after 2 days (Fig. 3A). For shorter incubation times,
the difference was not significant. Interestingly, rather than increasing the
mitochondrial membrane potential, AX seemed to slow down a gradual loss of
membrane potential that may occur with time in culture. While a significant loss in
the membrane potential occurred from 6 hours to 2 days in culture without AX (Fig.
3B, p < 0.001), no significant difference/loss could be detected in the presence of AX.
3.4. AX effect on respiratory control
Speculating that a decrease in mitochondrial membrane could also affect
mitochondrial respiration, we measured the oxygen consumption of intact HeLa cells
cultured under the same conditions. Measuring first baseline oxygen consumption (no
additions), then the mitochondrial state 4 consumption (by blocking complex V with
oligomycin) and then maximal oxygen consumption by uncoupling mitochondria with
DNP (80 µM) (Fig. 4A), we could not observe significant changes in the absolute
consumption rates (Fig. 4B), but the ratio of baseline to uncoupled oxygen
consumption was significantly higher in the presence of AX, i.e. mitochondria were
more active in the presence of AX (Fig.4C). In addition, the relative reduction in
oxygen consumption upon addition of oligomycin was increased in the presence of
AX (Fig. 4C). Together, these findings suggest that AX stimulates respiration
probably by maintaining a higher membrane potential (Fig. 3).
3.5. AX improves the mitochondrial redox state
Due to these positive but rather subtle effects of AX on mitochondrial
function, we looked for a sensitive method to detect relatively mild oxidative stress at
the organelle level. We chose redox-sensitive GFP as a promising method, since it is
ratiometric and can be targeted to various cellular compartments [20,21,30] .
Furthermore, it has been shown to be a quantitative sensor for the redox potential of
the cellular glutathione redox buffer [31]. HeLa cells were stably tranfected with the
expression vector for roGFP1 targeted to mitochondria as described above and the
colocalization of roGFP1 with mitochondria confirmed using confocal microscopy.
RoGFP1 showed almost perfect overlap with the mitochondrial marker dye TMRM
(Fig. 5A). Cells expressing mitochondrial roGFP1 showed no abnormal morphology
(Fig. 5A&B) and mitochondria exhibited the characteristic tubular shape and
movement presumably along microtubules (Suppl. Movie). The mitochondrial redox
state of individual cells was measured using dual excitation imaging (Fig. 5C).
Mitochondrial roGFP1 (basal redox state) was more reduced in cells cultured with AX
for 6 h, 1 day and 2 days (Fig. 5D&E). Mitochondrial ability to maintain the reducing
environment was then tested by exposing cells to 100 µM H
, which quickly
oxidized mitochondrial roGFP1, but significantly less so when AX was present (Fig.
5D&E). To exclude the possibility that the more reduced state after addition of H
simply a consequence of the more reduced (basal) state prior to addition of H
, we
also compared the change in fluorescence ratio induced by H
. This difference was
also significantly smaller in the presence of AX (Fig. 5E). Whether this antioxidant
effect of AX was limited to mitochondria or also extended to the cytosol was tested
using cells expressing roGFP1 in the cytosol (Fig.6A). The basal redox state and
resistance to oxidative challenge with H
was tested in the same manner as for
mitochondria, but no effect of AX on the redox state of the cytosol could be detected
(Fig. 6B).
4. Discussion
Above results demonstrate that, under basal conditions, AX had a small but
significant positive effect on mitochondrial function (higher membrane potential,
higher respiratory control). This is reassuring, since endogenous oxidative stress,
though clearly present [32], should be rather mild in the absence of external stress
inducing agents. Since mitochondria are a major source of ROS in the cell,
accumulation of AX in the mitochondrial membrane would potentiate its antioxidant
effects. There is a report showing AX protects mesangial cells from
hyperglycemia-induced oxidative signaling [33]. The fact that AX was able to
maintain mitochondria but not the cytosol in a reduced state (Fig. 5) indicates that the
effect of AX is, at least during mild, endogenous oxidative stress, concentrated on
mitochondria. The effect of AX became more pronounced with incubation time.
Interestingly, such a time dependency was also observed in an investigation of the
antitumour activity of AX [34]. AX, at a total serum concentration of approximately
1.2 µM suppressed tumour cell growth when mice were fed AX before inoculation,
but was ineffective when the AX-supplemented diet was started at the same time as
tumor inoculation [34].
Cell types differ in their dependence on mitochondria-generated ATP as a
source of energy and in their sensitivity to oxidative stress. Mitochondria isolated
from PC12 cells had oxygen consumption rates similar to isolated rat liver
mitochondria (data not shown) [35]. The dopaminergic, neuron-like cell line PC12 is
very sensitive to oxidative stress, and oxidative stress-induced cytotoxicity in PC12
cells is frequently employed as an in vitro model of Parkinson’s disease [27,36]. AX
protected PC12 cells against antimycin A-induced cell death. HeLa cells, in contrast,
can rely on glycolysis as the sole energy supply and survive even in the absence of a
functional electron transport chain [37]. Accordingly, blocking electron transport with
antimycin A, though clearly inducing oxidative stress, does not necessarily lead to
HeLa cell death [38,39]. That AX was protective in both cells lines indicates that the
effect of AX should not be cell type or cancer specific.
Although direct superoxide scavenging by a highly water-dispersible
carotenoid phospholipid has been reported at high concentrations [40], AX may not
exert its strong effect by scavenging superoxide. In fact, under conditions of acute
oxidative stress when large amounts of ROS are produced, AX showed no detectable
effect, indicating that the effects of AX are not due direct scavenging of ROS such as
superoxide or peroxides (Fig. 2A). This is to be expected since superoxide is a
charged radical unable to cross cellular membranes and carotenoids are extremely
lipophilic. On the other hand, since AX reduced the endogenous oxidative stress level
(Fig. 2D), it is reasonable to assume it protects cells against oxidative damage in the
lipd phase (Fig. 1). Thus, even though it may not svavenge ROS directly, AX has the
potential to protect cells against damage mediated by oxidative stress. Since ROS
including superoxide and hydrogen peroxide play significant roles in the signal
transduction at low concentrations[41], this characteristic of AX suggests little
possibilities of negative side effects of AX consumption.
The increase in mitochondrial oxygen consumption of AX-treated cells is
probably in part a consequence of the change in mitochondrial membrane
potential[41]. The relatively higher reduction in oxygen consumption upon addition of
oligomycin in the presence of AX would be expected as mitochondrial membrane
potential is higher in the presence of AX, while in the absence of AX, oligomycin is
unable to increase membrane potential to the same level. Such an inhibition of
respiration upon inactivation of complex V is referred to as “respiratory control ratio”,
an important measure of mitochondrial health when investigating isolated
mitochondria [41], even though it should be pointed out that we used intact cells,
where respiration during stimulation of complex V with ADP is not accessible, and
the ratios are not comparable. Physiological effects of AX have been shown to include
stimulation of β-oxidation for fatty acids [42,43]. This would be of considerable
benefit in reducing obesity and metabolic syndrome in affluent societies. Much of the
benefit of one of the most effective drugs for diabetes, metformin, has been attributed
to activation of AMP-dependent kinase, which helps by reducing gluconeogenesis and
driving oxidation of fat in muscle mitochondria [44]. The AX concentration upon
which a significant benefit could be observed (200nM, Fig. 1) is also well within the
range that can be achieved with supplementation. A single oral dose of 10 mg AX
resulted in a peak plasma concentration of ~130 nM, whereas a single dose of 100 mg
AX resulted in a peak plasma concentration of ~470 nM, with half lives in the order
of days [25]. Similarly, daily consumption of 250 g either wild or farmed salmon
(farmed salmon is fed synthetic AX to give it its natural coloring) lead to a plateau of
~50 nM AX in plasma after about 6 days [26].
Redox-sensitive GFP targeted to mitochondria could detect changes in the
mitochondrial redox state even after short incubation with AX, where conventional
methods failed. This indicates that roGFP is a powerful tool to measure oxidative
stress and redox balance at the organelle level. Targeting roGFP to mitochondria
allowed us to detect changes in the mitochondrial redox state that were too small to
affect the cytosol. Redox-sensitive GFP possibly interacts with a number of cellular
enzymes and redox couples, but it is still unclear which determine the roGFP1 redox
state to what extent. The reduction of roGFP1 is likely enzyme-dependent, as
reductase and dehydrogenase inhibitors reduced or prevented reduction of the close
cousin roGFP2 in the cytosol [20]. Conversely, oxidation of roGFP proceeded
considerably faster when, compared to the isolated protein, it was expressed in cells,
suggesting that the oxidation is also catalyzed by intracellular enzymes. In our hands,
the response of roGFP1 to hydrogen peroxide was also significantly faster than
previously reported [20]. RoGFP oxidation was observed immediately, and the
maximum response in the cytosol was reached within five minutes (Fig. 6B).
The high sensitivity of roGFP to changes in organelle redox state suggest that
it is a powerful tool to investigate the biochemistry of oxidative stress and redox
balance at the organelle level. Accurate measurement of oxidative stress is an ongoing
challenge, and despite the availability and ongoing development of a wide range of
probes and methods, their correct use is often complicated (for example [45]) and/or
cumbersome (for example [46]). The most widely employed method to “quantify”
ROS, the conversion of dichlorodihydrofluorescein (H
DCF) to DCF, requires a
catalyst for H
DCF to be oxidized by hydrogen peroxide and reacts indiscriminately
with a variety of oxidizing factors, including light and itself [47,48].
RoGFP1 is a relatively new non-destructive and ratiometric sensor for cellular
redox state [20,21] permitting a wide range of measurements previously impossible or
extremely labour-intensive and therefore open to errors and artefacts. Experiments to
establish the sensitivity of roGFP1 to various stressors and antioxidants are currently
under way in our laboratory, but in our opinion, roGFP offers great promise for
pin-point detection of oxidative stress. Targeting roGFP1 to subcellular structures
allowed us to observe oxidative stress restricted to mitochondria without affecting the
cytosol, demonstrating that changes in redox state and oxidative stress can be
confined to cellular compartments. To understand cellular redox states, it might
therefore be important to determine compartmental redox states independently.
Furthermore, transgenic animals expressing roGFPs should be a valuable tool to test
the efficacy of treatments aimed at reducing oxidative stress.
We express our deep gratitude to Prof. Jim Remington and his team for kindly
providing the roGFP1 containing plasmids. Alexander Wolf was supported by a
Postdoctoral Fellowship and grant from the Japan Society for the Promotion of
List of Abbreviations
AX, astaxanthin; CCD, charge coupled device; DCF, 2’,7’-dichlorofluorescein;
DMEM/F12, Dulbecco’s Modified Eagle Medium / F-12 nutrient mixture; DNP,
2,4-dinitrophenol; FBS, fetal bovine serum; GFP, green fluorescent protein;
DCFDA, 2’,7’-dichlorodihydrofluorescein diacetate; HNE, 4-hydroxy-2-nonenal;
JC-1, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide; N.A.,
numerical aperture; PUFA, polyunsaturated fatty acid; roGFP, redox-sensitive green
fluorescent protein; TMRM, tetramethyl rhodamine methyl ester;
[1] Lusis AJ. Atherosclerosis. Nature 2000;407:233-241.
[2] Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M,
Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS.
Extension of murine life span by overexpression of catalase targeted to
mitochondria. Science 2005;308:1909-1911.
[3] Serrano M, Blasco MA. Cancer and ageing: convergent and divergent
mechanisms. Nat Rev Mol Cell Biol 2007;8:715-722.
[4] Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role
in multiple forms of insulin resistance. Nature 2006;440:944-948.
[5] Brownlee M. Biochemistry and molecular cell biology of diabetic
complications. Nature 2001;414:813-820.
[6] Beal MF. Bioenergetic approaches for neuroprotection in Parkinson's disease.
Ann Neurol 2003;53 Suppl 3:S39-47; discussion S47-38.
[7] Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in
Parkinson's disease. Science 2003;302:819-822.
[8] Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. A
review of specific dietary antioxidants and the effects on biochemical
mechanisms related to neurodegenerative processes. Neurobiol Aging
[9] Finkel T. Radical medicine: treating ageing to cure disease. Nat Rev Mol Cell
Biol 2005;6:971-976.
[10] Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY,
Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU.
Anti-obesity effects of alpha-lipoic acid mediated by suppression of
hypothalamic AMP-activated protein kinase. Nat Med 2004;10:727-733.
[11] Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate
attenuates diet-induced obesity in mice by decreasing energy absorption and
increasing fat oxidation. Int J Obes (Lond) 2005;29:615-623.
[12] Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by
resveratrol. J Biol Chem 2005;280:17187-17195.
[13] Ridinger MH. Nutraceuticals: miracle or meme? Clin Pharmacol Ther
[14] Kamel NS, Gammack J, Cepeda O, Flaherty JH. Antioxidants and hormones
as antiaging therapies: high hopes, disappointing results. Cleve Clin J Med
2006;73:1049-1056, 1058.
[15] Hansen JM, Go YM, Jones DP. Nuclear and mitochondrial compartmentation
of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol
[16] Thomson MJ, Puntmann V, Kaski JC. Atherosclerosis and oxidant stress: the
end of the road for antioxidant vitamin treatment? Cardiovasc Drugs Ther
[17] Vickers AJ. Which botanicals or other unconventional anticancer agents
should we take to clinical trial? J Soc Integr Oncol 2007;5:125-129.
[18] Chinta SJ, Andersen JK. Reversible inhibition of mitochondrial complex I
activity following chronic dopaminergic glutathione depletion in vitro:
implications for Parkinson's disease. Free Radic Biol Med 2006;41:1442-1448.
[19] Miyawaki A, Nagai T, Mizuno H. Engineering fluorescent proteins. Adv
Biochem Eng Biotechnol 2005;95:1-15.
[20] Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY.
Imaging dynamic redox changes in mammalian cells with green fluorescent
protein indicators. J Biol Chem 2004;279:22284-22293.
[21] Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, Tsien RY,
Remington SJ. Investigating mitochondrial redox potential with
redox-sensitive green fluorescent protein indicators. J Biol Chem
[22] Hussein G, Sankawa U, Goto H, Matsumoto K, Watanabe H. Astaxanthin, a
carotenoid with potential in human health and nutrition. J Nat Prod
[23] Higuera-Ciapara I, Felix-Valenzuela L, Goycoolea FM. Astaxanthin: a review
of its chemistry and applications. Crit Rev Food Sci Nutr 2006;46:185-196.
[24] Gross GJ, Hazen SL, Lockwood SF. Seven day oral supplementation with
Cardax (disodium disuccinate astaxanthin) provides significant
cardioprotection and reduces oxidative stress in rats. Mol Cell Biochem
[25] Coral-Hinostroza GN, Ytrestoyl T, Ruyter B, Bjerkeng B. Plasma appearance
of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men
given single doses of a mixture of optical 3 and 3'R/S isomers of astaxanthin
fatty acyl diesters. Comp Biochem Physiol C Toxicol Pharmacol
[26] Rufer CE, Moeseneder J, Briviba K, Rechkemmer G, Bub A. Bioavailability
of astaxanthin stereoisomers from wild (Oncorhynchus spp.) and aquacultured
(Salmo salar) salmon in healthy men: a randomised, double-blind study. Br J
Nutr 2007:1-7.
[27] Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, Liu RM, Forman
HJ, Andersen JK. Glutathione depletion in PC12 results in selective inhibition
of mitochondrial complex I activity. Implications for Parkinson's disease. J
Biol Chem 2000;275:26096-26101.
[28] Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K,
Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic
antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med
[29] Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a
quantitative fluorescent indicator of membrane potential. Biochemistry
[30] Schwarzer C, Illek B, Suh JH, Remington SJ, Fischer H, Machen TE.
Organelle redox of CF and CFTR-corrected airway epithelia. Free Radic Biol
Med 2007;43:300-316.
[31] Meyer AJ, Brach T, Marty L, Kreye S, Rouhier N, Jacquot JP, Hell R.
Redox-sensitive GFP in Arabidopsis thaliana is a quantitative biosensor for the
redox potential of the cellular glutathione redox buffer. Plant J
[32] Choksi KB, Nuss JE, Boylston WH, Rabek JP, Papaconstantinou J.
Age-related increases in oxidatively damaged proteins of mouse kidney
mitochondrial electron transport chain complexes. Free Radic Biol Med
[33] Manabe E, Handa O, Naito Y, Mizushima K, Akagiri S, Adachi S, Takagi T,
Kokura S, Maoka T, Yoshikawa T. Astaxanthin protects mesangial cells from
hyperglycemia-induced oxidative signaling. J Cell Biochem 2007.
[34] Jyonouchi H, Sun S, Iijima K, Gross MD. Antitumor activity of astaxanthin
and its mode of action. Nutr Cancer 2000;36:59-65.
[35] Schwerzmann K, Cruz-Orive LM, Eggman R, Sanger A, Weibel ER.
Molecular architecture of the inner membrane of mitochondria from rat liver: a
combined biochemical and stereological study. J Cell Biol 1986;102:97-103.
[36] Yamamoto N, Sawada H, Izumi Y, Kume T, Katsuki H, Shimohama S, Akaike
A. Proteasome inhibition induces glutathione synthesis and protects cells from
oxidative stress: relevance to Parkinson disease. J Biol Chem
[37] Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. Introduction of
disease-related mitochondrial DNA deletions into HeLa cells lacking
mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci
U S A 1991;88:10614-10618.
[38] Lyamzaev KG, Izyumov DS, Avetisyan AV, Yang F, Pletjushkina OY,
Chernyak BV. Inhibition of mitochondrial bioenergetics: the effects on
structure of mitochondria in the cell and on apoptosis. Acta Biochim Pol
[39] Han YH, Kim SH, Kim SZ, Park WH. Antimycin A as a mitochondria damage
agent induces an S phase arrest of the cell cycle in HeLa cells. Life Sci
[40] Foss BJ, Sliwka HR, Partali V, Cardounel AJ, Zweier JL, Lockwood SF. Direct
superoxide anion scavenging by a highly water-dispersible carotenoid
phospholipid evaluated by electron paramagnetic resonance (EPR)
spectroscopy. Bioorg Med Chem Lett 2004;14:2807-2812.
[41] Ainscow EK, Brand MD. Internal regulation of ATP turnover, glycolysis and
oxidative phosphorylation in rat hepatocytes. Eur J Biochem
[42] Aoi W, Naito Y, Takanami Y, Ishii T, Kawai Y, Akagiri S, Kato Y, Osawa T,
Yoshikawa T. Astaxanthin improves muscle lipid metabolism in exercise via
inhibitory effect of oxidative CPT I modification. Biochem Biophys Res
Commun 2008;366:892-897.
[43] Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin in obese
mice fed a high-fat diet. Biosci Biotechnol Biochem 2007;71:893-899.
[44] Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J,
Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of
AMP-activated protein kinase in mechanism of metformin action. J Clin Invest
[45] Johnson-Cadwell LI, Jekabsons MB, Wang A, Polster BM, Nicholls DG. 'Mild
Uncoupling' does not decrease mitochondrial superoxide levels in cultured
cerebellar granule neurons but decreases spare respiratory capacity and
increases toxicity to glutamate and oxidative stress. J Neurochem
[46] Arneson KO, Roberts LJ, 2nd. Measurement of products of docosahexaenoic
acid peroxidation, neuroprostanes, and neurofurans. Methods Enzymol
[47] Wrona M, Wardman P. Properties of the radical intermediate obtained on
oxidation of 2',7'-dichlorodihydrofluorescein, a probe for oxidative stress. Free
Radic Biol Med 2006;41:657-667.
[48] Wrona M, Patel KB, Wardman P. The roles of thiol-derived radicals in the use
of 2',7'-dichlorodihydrofluorescein as a probe for oxidative stress. Free Radic
Biol Med 2008;44:56-62.
Figure legends
Fig. 1. Astaxanthin effect on PC12 cell survival under oxidative stress. Cells were
cultured in the presence of 0, 100, 200 and 400 nM astaxanthin (AX) for 6 hours or 24
hours and then exposed to 30 µg/ml antimycin A as described under cell viability in
Materials and methods. No effect was detected when cells were preincubated with AX
for 6 hours. When preincubated with AX for 24 hours, cells were protected against
cell death induced by oxidative stress, significantly for 200 and 400 nM AX (p < 0.01).
Data are means ± SD from 3 fields containing 100-200 cells each.
Fig. 2. Superoxide and oxidative stress. (A) PC12 cells were preincubated with
astaxanthin (AX) for indicated periods, followed by exposure to antimycin A to
induce superoxide. Superoxide, as measured using MitoSOX Red, was not changed
significantly by culturing cells with AX. Data were obtained as the means ± SD by
quantifying signal intensities of 70 100 cells. (B) Superoxide production is
induced by incubating Jurkat cells with 30 µg/ml antimycin A. (C) Jurkat cells
cultivated in the presence or absence (DMSO) of AX (800 nM) for 6 h, 1 day, and 2
days were treated with antimycin A (30 µ g/ml). No significant difference in the
amount of oxidized MitoSOX Red was observed, indicating that, under conditions of
oxidative stress and at a concentration of 800 nM, AX is unable to scavenge
significant amounts of superoxide (D) Basal oxidative stress level in cells, as
measured by incubating cells with H
DCFDA. AX significantly decreased the amount
of DCF produced in HeLa cells incubated with AX for 2 days (n = 383 cells, control:
n = 403 cells; from 3 independent experiments each condition). *** p < 0.001. (E)
Antimycin A (30 µg/ml) also induced acute oxidative stress as assessed using
DCFDA. The amount of DCF produced was increased more than tenfold. (F)
Similar to C, AX did not reduce acute oxidative stress. No significant difference in the
amount of DCF was observed.
Fig. 3. Mitochondrial membrane potential (A) Representative transmitted light (upper
row) and membrane potential (lower row) images of Hela cells cultured for 2 days in
the presence (right) or absence (left) of 800 nM astaxanthin (AX). The membrane
potential image was created by color coding the dual excitation fluorescence ratio.
Asterisks (pink) mark the approximate positions of cell nuclei. (B) Average JC-1 dual
excitation fluorescence ratio from 3 independent experiments, with fluorescence
recorded at 2 locations for each experiment. Membrane potential was significantly
higher (p < 0.001) in the presence of AX after 2 days in culture, but rather than
increasing the mitochondrial membrane potential, AX seemed to prevent a loss of
membrane potential that occurred with increasing time in culture.
Fig. 4. Oxygen consumption profiles. (A) Representative traces of the oxygen
consumption of intact HeLa cells cultured with (800 nM, red trace) or without (black
trace) AX. Oligomycin and DNP were added at the indicated (arrows) time points.
(B) Average oxygen consumption per cell under baseline conditions (BL; dark gray
bars), in the presence of 2 µM oligomycin (+OM; black bars) and when uncoupled
with 80 µM DNP (+DNP, light gray bars). Data are the average ± SD of three
measurements of cells cultured for 6 hours (6H), 1 day (1D), or 2 days (2D) in the
presence or absence of 800 nM astaxanthin (AX) (control: DMSO). (C) AX increased
the ratio of baseline divided by uncoupled oxygen consumption and decreased the
ratio of oxygen consumption in the presence of oligomycin divided by baseline
oxygen consumption. Data are mean ± SD. ** p < 0.01.
Fig. 5. Mitochondrial redox state measured using redox sensitive GFP. (A) Confocal
and transmitted light images of a HeLa cell expressing roGFP1 targeted to
mitochondria. Overlap of TMRM and roGFP1 fluorescence confirms mitochondrial
localization of roGFP1. Scale bar: 20 µm. (B) Epifluorescence image of HeLa cells
expressing roGFP1 targeted to mitochondria. Regions automatically selected for
analysis are marked in pink. Scale bar: 20 µm. (C) Representative traces of the
roGFP1 redox state time course (dual excitation fluorescence ratio). Four individual
cells show the hetereogeneity of mitochondrial redox state between cells. After the
indicated periods, 100 µM hydrogen peroxide was added (arrow). (D) Average time
course indicating mitochondrial redox state of cells cultured with or without 800 nM
astaxanthin (AX) for 6 h (6H)(+AX: n = 35 cells, control: n = 34 cells), 1 day
(1D)(+AX: n = 41 cells, control: n = 32 cells), or 2 days (2D)(+AX: n = 32 cells,
control: n = 27 cells). Average baseline as well as redox state after addition of 100
µM hydrogen peroxide (arrow) was more reduced when AX was present. (E) Average
baseline fluorescence ratio, ratio after addition of hydrogen peroxide, and amount of
oxidation (ratio difference) induced by hydrogen peroxide, was significantly lower, i.e.
reduced, when AX was present. Data are mean ± SD. *p < 0.05, **p < 0.01, ***p <
Fig. 6. Effect of astaxanthin on the cytosol redox state. (A) Epifluorescence image of
HeLa cells expressing roGFP1 in the cytosol. Regions automatically selected for
analysis as individual cells are marked in pink. Scale: 20 µm. (B) Timecourse of
cytosol redox state (410/490 nm dual excitation fluorescence ratio) upon addition of
100 µM H
(arrow). No difference was detected, neither in the basal redox state nor
in the change or state after addition of H
, between cells cultured for 2 days in the
presence (open diamonds, n = 73 cells) or absence (filled diamonds, n = 90 cells) of
800 nM astaxanthin.
Supplementary Movie. Cells expressing roGFP1 targeted to mitochondria were
cultured in the presence (800 nM, upper row) or absence (DMSO, lower row) of AX
for one day (left column) or two days (right column) and observed for 5 minutes. One
image was taken every two seconds using a 63X immersion objective and 410 nm
wavelength excitation.
... This report challenged PC12 cells with antimycin A (AnA), which inhibit Complex III triggering ROS overproduction, resulting in cytotoxicity. AX pre-treatment showed a time-and dose-dependent protective effect of AnA-treated PC12 cells, using sub-nanomolar amounts of AX [78]. This treatment did not cause cell death in HeLa or Jurkat cells, which have the ability to utilize the glycolytic pathway, bypassing the mitochondrial ETC. ...
... Wolf et al., evaluated the activity of the mitochondrial respiratory chain in HeLa cells and found that the addition of AX increased oxygen consumption in the basal condition, but did not observe any significant changes in the maximal oxygen consumption in the presence of the mitochondrial uncoupler, oligomycin [78]. Therefore, the ratio of baseline to uncoupled oxygen consumption was significantly higher in the presence of AX. ...
Full-text available
Astaxanthin is a member of the carotenoid family that is found abundantly in marine organisms, and has been gaining attention in recent years due to its varied biological/physiological activities. It has been reported that astaxanthin functions both as a pigment, and as an antioxidant with superior free radical quenching capacity. We recently reported that astaxanthin modulated mitochondrial functions by a novel mechanism independent of its antioxidant function. In this paper, we review astaxanthin’s well-known antioxidant activity, and expand on astaxanthin’s lesser-known molecular targets, and its role in mitochondrial energy metabolism.
... This decreases lipid peroxidation and does not produce harmful pro-oxidative effects [29]. Furthermore, ASX inhibition of lipid peroxidation is related to its ability to trap ROS within and on both sides of the membrane [30]. Growing evidence suggests that ASX improves mitochondrial function by reducing the impact of mitochondrial ROS, increasing ATP production, and increasing mitochondrial number and respiratory chain complex activity [31,32]. ...
... Ferro et al. [39] have shown that dietary supplements of ASX support mitochondrial function, protecting its redox balance. Astaxanthin significantly reduced oxidative stress and kept mitochondria in a reduced state, even after exposure to H 2 O 2 [30]. Astaxanthin also prevented the loss of the mitochondrial membrane potential and the escape of electrons with increased consumption of oxygen by mitochondria [40]. ...
Full-text available
Astaxanthin (ASX) is a natural product and one of the most powerful antioxidants known. It has significant effects on the metabolism of many animals, increasing fecundity, egg yolk volume, growth rates, immune responses, and disease resistance. A large part of the bioactivity of ASX is due to its targeting of mitochondria, where it inserts itself into cell membranes. Here, ASX stabilizes membranes and acts as a powerful antioxidant, protecting mitochondria from damage by reactive oxygen species (ROS). ROS are ubiquitous by-products of energy metabolism that must be tightly regulated by cells, lest they bind to and inactivate proteins, DNA and RNA, lipids, and signaling molecules. Most animals cannot synthesize ASX, so they need to acquire it in their diet. ASX is easily thermally denatured during extraction, and its high hydrophobicity limits its bioavailability. Our focus in this review is to contrast the bioactivity of different ASX stereoisomers and how extraction methods can denature ASX, compromising its bioavailability and bioactivity. We discuss the commercial sources of astaxanthin, structure of stereoisomers, relative bioavailability and bioactivity of ASX stereoisomers, mechanisms of ASX bioactivity, evolution of carotenoids, and why mitochondrial targeting makes ASX such an effective antioxidant.
... This may be related to the high level of astaxanthin in krill oil, which is regarded as an effective antioxidant against lipid peroxidation and oxidative stress (Ambati et al., 2014). Many studies have shown that astaxanthin can protect mitochondrial redox state and functional integrity from oxidative stress (Wolf et al., 2010;Lee et al., 2011;Kim and Kim, 2018). Thus, dietary krill oil could reduce the negative effects of high level of n-3 LC-PUFA, promote the capacity against the lipid peroxidation and prevent a condition of oxidative damage, and further ameliorate the mitochondrial function. ...
Full-text available
Organisms can regulate mitochondrial metabolic adaptation, further ameliorate the energy homeostasis to control the ATP production for the energy expenditure during the growth process under different physiological and nutritional conditions. Based on this understanding, the objective of the present study was to investigate how different dietary n-3 PUFA (polyunsaturated fatty acid) lipid sources modify the mitochondrial metabolic adaptation, and further affect the energy homeostasis and the growth of swimming crab (Portunus trituberculatus). A total of 120 swimming crab juveniles with an average initial weight of 10.17 ± 0.12 g were fed one of three diets (4 replicates/treatment) containing either fish oil (control), krill oil or linseed oil as dietary lipid sources for 8 weeks, and the effects of dietary lipid sources on the growth and energy homeostasis via the regulation of mitochondrial metabolic adaptation were evaluated. The study revealed that, compared with linseed oil rich in 18:3n-3, fish oil and krill oil rich in 20:5n-3 and 22:6n-3 significantly promoted the molting and growth of juvenile swimming crab, increased the ATP level, mitochondrial membrane potential, NAD+ substrate level, NAD+/NADH ratio and the mitochondrial DNA copy number. Furthermore, crabs fed the diet supplemented with krill oil can up-regulate the expression levels of genes related to energy metabolism. In addition, dietary krill oil also specifically improved the ability for scavenging free radicals produced in the process of physiological metabolism, reduced the level of lipid peroxidation and the degree of DNA oxidative damage, and improved the health status of swimming crab. The present study revealed the adaptation of mitochondrial metabolism and the regulation of the energy homeostasis of swimming crab to different dietary n-3 PUFA lipid sources, and provided a new insight into the relationship between the growth as well as molting and the energy homeostasis, which provided a novel insight into the lipid nutrition and energy metabolism of crustacean species.
... Astaxanthin (ATX), a xanthophyll carotenoid, has strong antioxidant capacity by scavenging free radicals, quenching singlet oxygen, enhancing antioxidant enzymes and inhibiting lipid peroxidation [12]. Meanwhile, it is associated with maintaining the mitochondrial redox state and functional integrity against oxidative stress [13]. However, due to severe restriction of the blood-labyrinth barrier, lack of sufficient drug concentrations in the inner ear often exist after intravenous injection or oral intake (systemic administration) [14]. ...
Full-text available
Background Excessive accumulation of reactive oxygen species (ROS) has been documented as the crucial cellular mechanism of cisplatin-induced ototoxicity. However, numerous antioxidants have failed in clinical studies partly due to inefficient drug delivery to the cochlea. A drug delivery system is an attractive strategy to overcome this drawback. Methods and results In the present study, we proposed the combination of antioxidant astaxanthin (ATX) and ROS-responsive/consuming nanoparticles (PPS-NP) to combat cisplatin-induced ototoxicity. ATX-PPS-NP were constructed by the self-assembly of an amphiphilic hyperbranched polyphosphoester containing thioketal units, which scavenged ROS and disintegrate to release the encapsulated ATX. The ROS-sensitivity was confirmed by ¹H nuclear magnetic resonance spectroscopy, transmission electron microscopy and an H2O2 ON/OFF stimulated model. Enhanced release profiles stimulated by H2O2 were verified in artificial perilymph, the HEI-OC1 cell line and guinea pigs. In addition, ATX-PPS-NP efficiently inhibited cisplatin-induced HEI-OC1 cell cytotoxicity and apoptosis compared with ATX or PPS-NP alone, suggesting an enhanced effect of the combination of the natural active compound ATX and ROS-consuming PPS-NP. Moreover, ATX-PPS-NP attenuated outer hair cell losses in cultured organ of Corti. In guinea pigs, NiRe-PPS-NP verified a quick penetration across the round window membrane and ATX-PPS-NP showed protective effect on spiral ganglion neurons, which further attenuated cisplatin-induced moderate hearing loss. Further studies revealed that the protective mechanisms involved decreasing excessive ROS generation, reducing inflammatory chemokine (interleukin-6) release, increasing antioxidant glutathione expression and inhibiting the mitochondrial apoptotic pathway. Conclusions Thus, this ROS-responsive nanoparticle encapsulating ATX has favorable potential in the prevention of cisplatin-induced hearing loss. Graphical Abstract
... All-trans astaxanthin is a natural carotenoid with both antioxidant and neuroprotective effects [15], mainly from marine organisms. On one hand, astaxanthin in nerve cells protects the mitochondria against endogenous oxygen radicals, conserves their antioxidant capacity, and enhances energy production efficiency [16]. On the other hand, unreasonable intracellular levels of lipid peroxide might cause damage to lipids and proteins [17], thus malondialdehyde as potential biomarker is one of the most frequently used indicators of lipid peroxidation [18]. ...
Full-text available
Alzheimer´s disease is a global neurodegenerative health concern. To prevent the disease, the simultaneous inhibition of acetylcholinesterase and oxidative stress is an efficient approach. In this study, the inhibition effect of all-trans astaxanthin mainly from marine organisms on acetylcholinesterase and oxidative stress was evaluated by a chemical-based method in vitro and cell assay model. The results show that all-trans astaxanthin was a reversible competitive inhibitor and exhibited a strong inhibition effect with half inhibitory concentration (IC50 value) of 8.64 μmol/L. Furthermore, all-trans astaxanthin inhibited oxidative stress through reducing malondialdehyde content and increasing the activity of superoxide dismutase as well as catalase. All-trans astaxanthin could induce the changes of the secondary structure to reduce acetylcholinesterase activity. Molecular-docking analysis reveals that all-trans astaxanthin prevented substrate from binding to acetylcholinesterase by occupying the space of the active pocket to cause the inhibition. Our finding suggests that all-trans astaxanthin might be a nutraceutical supplement for Alzheimer´s disease prevention.
... A positive effect of astaxanthin on sperm parameters and fertility has been proposed [106][107][108], whose molecular basis can be explained by the improvement of mitochondrial function. In fact, astaxanthin appears to be able to increase mitochondrial membrane potential and respiratory control [109], which are important measures of mitochondrial functionality. ...
Full-text available
Diet might affect male reproductive potential, but the biochemical mechanisms involved in the modulation of sperm quality remain poorly understood. While a Western diet is considered a risk factor for male infertility, the Mediterranean diet seems to protect against male infertility; moreover, the role of a vegetarian habitus in the preservation of sperm quality is controversial. The aim of this review is to analyze the molecular effects of single nutrients on sperm quality, focusing on their involvement in biochemical mechanisms related to sperm bioenergetics. It appears that diets rich in saturated fatty acids (SFA) and low in polyunsaturated fatty acids (PUFA) negatively affect sperm quality, whereas unsaturated fatty acids supplementation ameliorates sperm quality. In fact, the administration of PUFA, especially omega-3 PUFA, determined an increase in mitochon- drial energetic metabolism and a reduction in oxidative damage. Carbohydrates and proteins are also nutritional modulators of oxidative stress and testosterone levels, which are strictly linked to sperm mitochondrial function, a key element for sperm quality. Moreover, many dietary natural polyphenols differentially affect (positively or negatively) the mitochondrial function, depending on their concentration. We believe that an understanding of the biochemical mechanisms responsible for sperm quality will lead to more targeted and effective therapeutics for male infertility.
... The herbal compound berberine, a nutraceutical long employed in diabetes treatment in China, shares the ability of metformin to activate AMPK [60][61][62][63][64]. Nutraceuticals that can amplify the transcriptional activity or expression of Nrf2 include lipoic acid, the sulforaphane generated from broccoli sprout extract, the neurohormone melatonin, and the xanthophyll carotenoid astaxanthin [58,[65][66][67][68]. Moreover, astaxanthin can also serve as an agonist for PPARα and can act as a highly effective scavenging antioxidant in the mitochondrial inner membrane [68,69]. ...
Full-text available
In people with metabolic syndrome, episodic exposure of pancreatic beta cells to elevated levels of both glucose and free fatty acids (FFAs)—or glucolipotoxicity—can induce a loss of glucose-stimulated insulin secretion (GSIS). This in turn can lead to a chronic state of glucolipotoxicity and a sustained loss of GSIS, ushering in type 2 diabetes. Loss of GSIS reflects a decline in beta cell glucokinase (GK) expression associated with decreased nuclear levels of the pancreatic and duodenal homeobox 1 (PDX1) factor that drives its transcription, along with that of Glut2 and insulin. Glucolipotoxicity-induced production of reactive oxygen species (ROS), stemming from both mitochondria and the NOX2 isoform of NADPH oxidase, drives an increase in c-Jun N-terminal kinase (JNK) activity that promotes nuclear export of PDX1, and impairs autocrine insulin signaling; the latter effect decreases PDX1 expression at the transcriptional level and up-regulates beta cell apoptosis. Conversely, the incretin hormone glucagon-like peptide-1 (GLP-1) promotes nuclear import of PDX1 via cAMP signaling. Nutraceuticals that quell an increase in beta cell ROS production, that amplify or mimic autocrine insulin signaling, or that boost GLP-1 production, should help to maintain GSIS and suppress beta cell apoptosis in the face of glucolipotoxicity, postponing or preventing onset of type 2 diabetes. Nutraceuticals with potential in this regard include the following: phycocyanobilin—an inhibitor of NOX2; agents promoting mitophagy and mitochondrial biogenesis, such as ferulic acid, lipoic acid, melatonin, berberine, and astaxanthin; myo-inositol and high-dose biotin, which promote phosphatidylinositol 3-kinase (PI3K)/Akt activation; and prebiotics/probiotics capable of boosting GLP-1 secretion. Complex supplements or functional foods providing a selection of these agents might be useful for diabetes prevention.
... Astaxanthin performs all these functions even after stimulation with H 2 O 2 . It proved that mitochondrial functions are sustained due to astaxanthin which protects mitochondrial redox balance (Kuroki et al., 2013;Wolf et al., 2010;Zhang et al., 2016). These findings suggested that astaxanthin can maintain mitochondrial integrity, prevent mitochondrial dysfunction, and reduce oxidative stress. ...
Full-text available
Oxidative stress caused by the imbalance between production of oxidants and antioxidants in the body leads to the development of different ailments. The bioactive compounds derived from marine sources are considered to be safe and appropriate to use. Astaxanthin possesses antioxidant activity about 100–500 times higher than other antioxidants such as α‐tocopherol and β‐carotene. It has numerous health benefits and vital pharmacological properties for the treatment of diseases like diabetes, hypertension, cancer, heart disease, ischemia, neurological disorders, and potential role in liver enzyme gamma‐glutamyl transpeptidase which has significance in medicine as a diagnostic marker. The primary source of astaxanthin among crustaceans is shrimps and the presence of astaxanthin protects shrimps from oxidation of polyunsaturated fatty acids and cholesterol. Conclusively, astaxanthin derived from shrimps is very effective against oxidative stress which can lead to certain ailments. Conclusively, the astaxanthin derived from shrimps is very effective against oxidative stress which become the cause of certain ailments.
Full-text available
Neuroinflammation is a protective mechanism against insults from exogenous pathogens and endogenous cellular debris and is essential for reestablishing homeostasis in the brain. However, excessive prolonged neuroinflammation inevitably leads to lesions and disease. The use of natural compounds targeting pathways involved in neuroinflammation remains a promising strategy for treating different neurological and neurodegenerative diseases. Astaxanthin, a natural xanthophyll carotenoid, is a well known antioxidant. Mounting evidence has revealed that astaxanthin is neuroprotective and has therapeutic potential by inhibiting neuroinflammation, however, its functional roles and underlying mechanisms in modulating neuroinflammation have not been systematically summarized. Hence, this review summarizes recent progress in this field and provides an update on the medical value of astaxanthin. Astaxanthin modulates neuroinflammation by alleviating oxidative stress, reducing the production of neuroinflammatory factors, inhibiting peripheral inflammation and maintaining the integrity of the blood-brain barrier. Mechanistically, astaxanthin scavenges radicals, triggers the Nrf2-induced activation of the antioxidant system, and suppresses the activation of the NF-κB and mitogen-activated protein kinase pathways. With its good biosafety and high bioavailability, astaxanthin has strong potential for modulating neuroinflammation, although some outstanding issues still require further investigation.
We evaluated the effects of a constant low (5-5%) and modulated (5–20%) oxygen environments on the in vitro development of bovine oocyte-cumulus-granulosa cell complexes (OCGCs) cultured in the presence or absence of an antioxidant (astaxanthin: Ax). OCGCs were cultured in a gas permeable culture device for 8 days in 5-5% O2 (±Ax) and 5–20% O2 (±Ax) culture conditions. In the oxygen modulated culture conditions, the oxygen concentration was switched from 5% to 20% on day 4 of culture. Ax promoted the viability of OCGCs (P < 0.05), but both oxygen and Ax had a significant effect on ROS production levels by OCGCs (P < 0.05). Specifically, ROS levels were significantly lower and higher under 5-5% O2 (+Ax) and 5–20% O2 (-Ax) conditions, respectively (P < 0.05), with intermediate levels observed in the 5-5% O2 (-Ax) and the 5–20% O2 (+Ax) culture conditions. The steroidogenic pattern was characterized by increasing estradiol-17β but with constant progesterone production levels regardless of culture conditions, suggesting the inhibition of luteinization-like changes in granulosa cells. OCGCs cultured in the 5–20% O2 (+Ax) had higher nuclear maturation rates (P < 0.05) that were similar to the oocytes grown in vivo. However, there was no clear difference in the subsequent cleavage rates among the 5-5% O2 (±Ax) and the 5–20% O2 (+Ax) culture conditions (P > 0.05). A constant low oxygen environment significantly promoted the blastocyst rates (P < 0.05); however, the presence of Ax in the 5–20% O2 (+Ax) condition also promoted development similar to the OCGCs cultured in the 5-5% O2 (-Ax) condition P > 0.05). In conclusion, exposure of OCGCs to constant low oxygen or oxygen modulation in the presence of Ax promotes the healthy development of OCGCs during the 8-day IVG culture using the gas permeable culture device.
Full-text available
Mutant mitochondrial DNA with large-scale deletions (delta-mtDNA) has been frequently observed in patients with chronic progressive external ophthalmoplegia (CPEO), a subgroup of the mitochondrial encephalomyopathies. To exclude involvement of the nuclear genome in expression of the mitochondrial dysfunction characteristic of CPEO, we introduced the mtDNA of a CPEO patient into clonal mtDNA-less HeLa cells and isolated cybrid clones. Quantitation of delta-mtDNA in the cybrids revealed that delta-mtDNA was selectively propagated with higher levels of delta-mtDNA correlating with slower cellular growth rate. In these cybrid clones, translational complementation of the missing tRNAs occurred only when delta-mtDNA was less than 60% of the total mtDNA, whereas accumulation of delta-mtDNA to greater than 60% resulted in progressive inhibition of overall mitochondrial translation as well as reduction of cytochrome c oxidase activity throughout the organelle population. Because these cybrids shared the same nuclear background as HeLa cells, these results suggest that large-scale deletion mutations of mtDNA alone are sufficient for the mitochondrial dysfunction characteristic of CPEO.
Full-text available
The molecular structure of mitochondria and their inner membrane has been studied using a combined approach of stereology and biochemistry. The amount of mitochondrial structures (volume, number, surface area of inner membrane) in a purified preparation of mitochondria from rat liver was estimated by stereological procedures. In the same preparation, the oxidative activity of the respiratory chain with different substrates and the concentration of the redox complexes were measured by biochemical means. By relating the stereological and biochemical data, it was estimated that the individual mitochondrion isolated from rat liver has a volume of 0.27 micron 3, an inner membrane area of 6.5 micron 2, and contains between 2,600 (complex I) and 15,600 (aa3) redox complexes which produce an electron flow of over 100,000 electrons per second with pyruvate as substrate. The individual redox complexes and the H+-ATPase together occur at a density of approximately 7,500/micron 2 and occupy approximately 40% of the inner membrane area. From the respective densities it was concluded that the mean nearest distance between reaction partners is small enough (70-200 A) to cause the formation of micro-aggregates. The meaning of these results for the mechanism of mitochondrial energy transduction is discussed.
Full-text available
Oxidative stress appears to play an important role in degeneration of dopaminergic neurons of the substantia nigra (SN) associated with Parkinson's disease (PD). The SN of early PD patients have dramatically decreased levels of the thiol tripeptide glutathione (GSH). GSH plays multiple roles in the nervous system both as an antioxidant and a redox modulator. We have generated dopaminergic PC12 cell lines in which levels of GSH can be inducibly down-regulated via doxycycline induction of antisense messages against both the heavy and light subunits of γ-glutamyl-cysteine synthetase, the rate-limiting enzyme in glutathione synthesis. Down-regulation of glutamyl-cysteine synthetase results in reduction in mitochondrial GSH levels, increased oxidative stress, and decreased mitochondrial function. Interestingly, decreases in mitochondrial activities in GSH-depleted PC12 cells appears to be because of a selective inhibition of complex I activity as a result of thiol oxidation. These results suggest that the early observed GSH losses in the SN may be directly responsible for the noted decreases in complex I activity and the subsequent mitochondrial dysfunction, which ultimately leads to dopaminergic cell death associated with PD.
Control analysis was used to analyse the internal control of rat hepatocyte metabolism. The reactions of the cell were grouped into nine metabolic blocks linked by five key intermediates. The blocks were glycogen breakdown, glucose release, glycolysis, lactate production, NADH oxidation, pyruvate oxidation, mitochondrial proton leak, mitochondrial phosphorylation and ATP consumption. The linking intermediates were intracellular glucose-6-phosphate, pyruvate and ATP levels, cytoplasmic NADH/NAD ratio and mitochondrial membrane potential. The steady-state fluxes through the blocks and the levels of the intermediates were measured in the absence and presence of specific effectors of hepatocyte metabolism. Application of the multiple modulation approach gave the kinetic responses of each block to each intermediate (the elasticities). These were then used to calculate all of the control coefficients, which describe the degree of control each block had over the level of each intermediate, and over the rate of each process. Within this full description of control, many different interactions could be identified. One key finding was that the processes that consumed ATP had only 35% of the control over the rate of ATP consumption. Instead, the reactions that produced ATP exerted the most control over ATP consumption rate; particularly important were mitochondrial phosphorylation (30% of control) and glycolysis (19%). The rate of glycolysis was positively controlled by the glycolytic enzymes themselves (66% of control) and by ATP consumption (47%). Mitochondrial production of ATP, including oxidative, proton leak and phosphorylation processes, had negative control over glycolysis (−26%; the Pasteur effect). In contrast, glycolysis had little control over the rate of ATP production by the mitochondria (−10%; the Crabtree effect). Control over the flux through the mitochondrial phosphorylation block was shared between pyruvate oxidation (23%), ATP consumption (28%) and the mitochondrial phosphorylation block itself (64%).
Antimycin A (AMA), an electron transport chain inhibitor in mitochondria can produce reactive oxygen species (ROS) in cells. It has been reported that ROS may have roles in cell cycle progression via regulating cell cycle-related proteins. In the present study, we investigated the changes of the cell cycle distribution in AMA-treated HeLa cells in relation to cell cycle-related proteins. DNA flow cytometric analysis indicated that treatment with AMA significantly induced an S phase arrest of the cell cycle at 72 h. AMA decreased the expression of cyclin-dependent kinase inhibitor (CDKI), p21 and p27, CDK4, and cdc2 proteins. The expression of CDK6, cyclin D1, cyclin E, cyclin A, and cyclin B proteins was increased by 0.5 microM AMA, but was decreased by 2 and 10 microM AMA. The phosphorylation of Rb on the Ser (780) residue was increased by 0.5 microM AMA. Furthermore, treatment with AMA caused the accumulation of cells expressing cyclin A, B, and D1 proteins at the S phase of the cell cycle. However, treatment with 100 microM AMA nonspecifically extended all phases of the cell cycle. In conclusion, treatment with AMA (2, 10 and 50 microM) induced an S phase arrest of the cell cycle. An S phase arrest was accompanied by the alteration of other cell cycle-regulated proteins as well as S phase-related proteins.
The spectral properties of a novel membrane potential sensitive probe (JC-1) were characterized in aqueous buffers and in isolated cardiac mitochondria. JC-1 is a carbocyanine with a delocalized positive charge. It formed under favorable conditions a concentration-dependent fluorescent nematic phase consisting of J-aggregates. When excited at 490 nm, the monomers exhibited an emission maximum at 527 nm and J-aggregates at 590 nm. Increasing concentrations of JC-1 above a certain concentration caused a linear rise in the J-aggregate fluorescence, while the monomer fluorescence remained constant. The membrane potential of energized mitochondria (negative inside) promoted a directional uptake of JC-1 into the matrix, also with subsequent formation of J-aggregates. The J-aggregate fluorescence was sensitive to transient membrane potential changes induced by ADP and to metabolic inhibitors of oxidative phosphorylation. The J-aggregate fluorescence was found to be pH independent within the physiological pH range of 7.15-8.0 and could be linearly calibrated with valinomycin-induced K+ diffusion potentials. The advantage of JC-1 over rhodamines and other carbocyanines is that its color altered reversibly from green to red with increasing membrane potentials. This can be exploited for imaging live mitochondria on the stage of a microscope.
Previously [Ainscow, E.K. & Brand, M.D. (1999) Eur. J. Biochem. 263, 671-685], top-down control analysis was used to describe the control pattern of energy metabolism in rat hepatocytes. The system was divided into nine reaction blocks (glycogen breakdown, glucose release, glycolysis, lactate production, NADH oxidation, pyruvate oxidation, mitochondrial proton leak, mitochondrial phosphorylation and ATP consumption) linked by five intermediates (intracellular glucose 6-phosphate, pyruvate and ATP levels, cytoplasmic NADH/NAD ratio and mitochondrial membrane potential). The kinetic responses (elasticities) of reaction blocks to intermediates were determined and used to calculate control coefficients. In the present paper, these elasticities and control coefficients are used to quantify the internal regulatory pathways within the cell. Flux control coefficients were partitioned to give partial flux control coefficients. These describe how strongly one block of reactions controls the flux through another via its effects on the concentration of a particular intermediate. Most flux control coefficients were the sum of positive and negative partial effects acting through different intermediates; these partial effects could be large compared to the final control strength. An important result was the breakdown of the way ATP consumption controlled respiration: changes in ATP level were more important than changes in mitochondrial membrane potential in stimulating oxygen consumption when ATP consumption increased. The partial internal response coefficients to changes in each intermediate were also calculated; they describe how steady state concentrations of intermediates are maintained. Increases in mitochondrial membrane potential were opposed mostly by decreased supply, whereas increases in glucose-6-phosphate, NADH/NAD and pyruvate were opposed mostly by increased consumption. Increases in ATP were opposed significantly by both decreased supply and increased consumption.
Astaxanthin, a carotenoid without vitamin A activity, may exert antitumor activity through the enhancement of immune responses. Here, we determined the effects of dietary astaxanthin on tumor growth and tumor immunity against transplantable methylcholanthrene-induced fibrosarcoma (Meth-A tumor) cells. These tumor cells express a tumor antigen that induces T cell-mediated immune responses in syngenic mice. BALB/c mice were fed astaxanthin (0.02%, 40 micrograms/kg body wt/day in a beadlet form) mixed in a chemically defined diet starting zero, one, and three weeks before subcutaneous inoculation with tumor cells (3 x 10(5) cells, 2 times the minimal tumorigenic dose). Three weeks after inoculation, tumor size and weight were determined. We also determined cytotoxic T lymphocyte (CTL) activity and interferon-gamma (IFN-gamma) production by tumor-draining lymph node (TDLN) and spleen cells by restimulating cells with Meth-A tumor cells in culture. The astaxanthin-fed mice had significantly lower tumor size and weight than controls when supplementation was started one and three weeks before tumor inoculation. This antitumor activity was paralleled with higher CTL activity and IFN-gamma production by TDLN and spleen cells in the astaxanthin-fed mice. CTL activity by TDLN cells was highest in mice fed astaxanthin for three weeks before inoculation. When the astaxanthin-supplemented diet was started at the same time as tumor inoculation, none of these parameters were altered by dietary astaxanthin, except IFN-gamma production by spleen cells. Total serum astaxanthin concentrations were approximately 1.2 mumol/l when mice were fed astaxanthin (0.02%) for four weeks and appeared to increase in correlation with the length of astaxanthin supplementation. Our results indicate that dietary astaxanthin suppressed Meth-A tumor cell growth and stimulated immunity against Meth-A tumor antigen.